Development of Antibiotic Regimens using Graph based Evolutionary Algorithms
Abstract
This paper examines the use of evolutionary algorithms in the development of antibiotic regimens given to production animals. A model is constructed that combines the lifespan of the animal and the bacteria living in the animal's gastro-intestinal tract from the early finishing stage until the animal reaches market weight. This model is used as the fitness evaluation for a set of graph based evolutionary algorithms to assess the impact of diversity control on the evolving antibiotic regimens. The graph based evolutionary algorithms have two objectives: to find an antibiotic treatment regimen that maintains the weight gain and health benefits of antibiotic use and to reduce the risk of spreading antibiotic resistant bacteria. This study examines different regimens of tylosin phosphate use on bacteria populations divided into Gram positive and Gram negative types, with a focus on Campylobacter spp. Treatment regimens were found that provided decreased antibiotic resistance relative to conventional methods while providing nearly the same benefits as conventional antibiotic regimes. By using a graph to control the information flow in the evolutionary algorithm, a variety of solutions along the Pareto front can be found automatically for this and other multi-objective problems. © 2013 Elsevier Ireland Ltd.
Recommended Citation
S. M. Corns et al., "Development of Antibiotic Regimens using Graph based Evolutionary Algorithms," BioSystems, vol. 114, no. 3, pp. 178 - 185, Elsevier, Jan 2013.
The definitive version is available at https://doi.org/10.1016/j.biosystems.2013.09.003
Department(s)
Engineering Management and Systems Engineering
Keywords and Phrases
Antibiotic; Evolutionary computation; Graph theory; Multi-objective
International Standard Serial Number (ISSN)
1872-8324; 0303-2647
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2024 Elsevier, All rights reserved.
Publication Date
01 Jan 2013
PubMed ID
24051263